4th Quarter - Report
BROWN RUDNICK LLP for PRIME THERAPEUTICS
Firm
Client
Income
$20,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues relating to prescription drug misuse by Medicare beneficiaries and Medicare Part D prescription drug plans.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA LAYMAN | SPA, Sen Stabenow(05-07) |
| HENRY W MENN | Min SD & Counsel, Cmte on Vet Affairs (04) |
Pharmacy PHA
Issues relating to generic pharmaceutical utilization MMM; Issues relating to the speciality tier drug category and prescription drug abuse in the medicare Part D program; The Medicare Prescription Drug Diversion and Abuse Prevention Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA LAYMAN | SPA, Sen Stabenow(05-07) |
| HENRY W MENN | Min SD & Counsel, Cmte on Vet Affairs (04) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.